Former NFL linebacker Bryan Braman, who won Super Bowl LII with the Philadelphia Eagles, has been diagnosed with a "very rare" and "life threatening" form of cancer on a GoFundMe page.

"Bryan is home with his family after undergoing a Car-t cell reprogramming treatment program in Seattle," the GoFundMe page, which was organized by William Jones in February, states. "With the cancer that Bryan has, which is a VERY rare form of cancer, the Car-t treatment had the highest chance of success as the cells are reprogrammed to fight this cancer that is within Bryan. His cells did re-infuse themselves, and did in fact start reproducing within his bone marrow. At first the mass did start to shrink, but then the cancer started fighting back. At this point Bryan has had to start having chemo treatments that are designed for the treatment program Bryan is in."

“By the time he was able to recover so he could continue with the chemo, the cancer has grown expedentially [sic] faster, and is is [sic] now growing around his vital organs,” Jones wrote in an update shared last month. “The Dr’s are now concerned because of his treatment, his chemo options are very limited. They have tried all of the various treatment options, and unfortunately, none of them are working against this cancer.

“But Bryan has not given up. He is looking into other trial treatment programs, and is determined to never give up.”

The GoFundMe page has exceeded its original goal of $25,000, with more than $46,000 raised as of Friday (July 4), which included a $10,000 donation from former All-Pro defensive end J.J. Watt, who was Braman's teammate with the Houston Texans.

Braman, like Watt, began his career with the Texans in 2011, however, signed as an undrafted free agent. The Spokane native appeared in 46 games for the franchise during his first three NFL seasons before signing a two-year deal with the Philadelphia Eagles in 2014.

Braman appeared in 51 regular season games during his final four seasons, which included three during the Eagles' Super Bowl LII run.